EFG Asset Management Americas Corp. Sells 179 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

EFG Asset Management Americas Corp. lessened its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 27.8% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 465 shares of the medical equipment provider’s stock after selling 179 shares during the period. EFG Asset Management Americas Corp.’s holdings in Intuitive Surgical were worth $207,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Creekmur Asset Management LLC grew its position in shares of Intuitive Surgical by 200.0% during the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 42 shares in the last quarter. Ridgewood Investments LLC acquired a new stake in Intuitive Surgical during the second quarter worth approximately $26,000. Able Wealth Management LLC bought a new position in Intuitive Surgical during the 4th quarter worth $28,000. Delos Wealth Advisors LLC raised its holdings in Intuitive Surgical by 380.0% in the 1st quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 57 shares in the last quarter. Finally, LRI Investments LLC bought a new stake in shares of Intuitive Surgical during the 1st quarter valued at $30,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analysts Set New Price Targets

ISRG has been the subject of a number of analyst reports. Truist Financial boosted their price target on Intuitive Surgical from $450.00 to $515.00 and gave the company a “buy” rating in a research note on Tuesday, July 16th. Robert W. Baird upped their price target on shares of Intuitive Surgical from $487.00 to $503.00 and gave the stock an “outperform” rating in a report on Friday, July 19th. Morgan Stanley boosted their price objective on shares of Intuitive Surgical from $375.00 to $460.00 and gave the company an “equal weight” rating in a research report on Monday, July 15th. JPMorgan Chase & Co. upped their target price on Intuitive Surgical from $475.00 to $495.00 and gave the stock an “overweight” rating in a research note on Friday, July 19th. Finally, Citigroup lifted their price target on Intuitive Surgical from $512.00 to $560.00 and gave the company a “buy” rating in a research note on Thursday, August 22nd. Six investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $446.45.

Intuitive Surgical Price Performance

ISRG opened at $471.82 on Friday. The company’s 50 day moving average price is $458.74 and its two-hundred day moving average price is $418.27. The firm has a market capitalization of $167.35 billion, a price-to-earnings ratio of 85.17, a PEG ratio of 5.43 and a beta of 1.39. Intuitive Surgical, Inc. has a fifty-two week low of $254.85 and a fifty-two week high of $493.97.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share for the quarter, topping the consensus estimate of $1.54 by $0.24. The company had revenue of $2.01 billion for the quarter, compared to analysts’ expectations of $1.97 billion. Intuitive Surgical had a net margin of 27.65% and a return on equity of 13.04%. Intuitive Surgical’s revenue for the quarter was up 14.5% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.18 earnings per share. As a group, equities research analysts predict that Intuitive Surgical, Inc. will post 5.22 EPS for the current year.

Insider Activity

In related news, Director Amal M. Johnson sold 2,943 shares of the company’s stock in a transaction that occurred on Thursday, August 1st. The stock was sold at an average price of $443.30, for a total value of $1,304,631.90. Following the sale, the director now directly owns 12,275 shares in the company, valued at $5,441,507.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, Director Amal M. Johnson sold 2,943 shares of Intuitive Surgical stock in a transaction on Thursday, August 1st. The shares were sold at an average price of $443.30, for a total transaction of $1,304,631.90. Following the completion of the transaction, the director now owns 12,275 shares of the company’s stock, valued at $5,441,507.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Robert Desantis sold 188 shares of the company’s stock in a transaction on Thursday, August 29th. The shares were sold at an average price of $482.21, for a total transaction of $90,655.48. Following the sale, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,655,048.26. The disclosure for this sale can be found here. Over the last quarter, insiders sold 51,656 shares of company stock valued at $24,700,644. Company insiders own 0.90% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.